FIELD: genetic engineering of proteins, medicine, pharmacy. SUBSTANCE: invention relates to recombinant antibody containing region of Old World monkey antibody and region of human antibody. Recombinant antibody consists of variable regions of heavy and light chains of immunoglobulin of Old World monkey and human constant regions. Antibody shows specificity to CD4. Recombinant antibody is a component of pharmaceutical composition that can be used for treatment of patients with psoriasis. EFFECT: valuable medicinal properties of recombinant antibody. 6 cl, 28 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ANTIBODY AGAINST CD4 FOR HUMAN THERAPY | 1996 |
|
RU2232773C2 |
| METHODS OF TREATMENT, ANTIBODIES, HYBRIDOMA | 1993 |
|
RU2139731C1 |
| ANTIBODY AGAINST PD-L1 | 2017 |
|
RU2744862C2 |
| RECOMBINANT ANTIBODIES AND COMPOSITIONS, METHODS FOR PRODUCTION AND USES THEREOF | 2002 |
|
RU2292353C2 |
| ENHANCEMENT OF IMMUNE RESPONSES MEDIATED BY PROTEINS FUSED FROM ANTIBODY AND CYTOKINE BY METHOD OF COMBINED ADMINISTRATION OF ANGIOGENESIS INHIBITOR | 1999 |
|
RU2229305C2 |
| ANTIBODY AGAINST PD-L1 | 2017 |
|
RU2744911C2 |
| METHOD OF CLONING COGNATE ANTIBODIES | 2008 |
|
RU2459868C2 |
| TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY | 2000 |
|
RU2305561C2 |
| RECOMBINANT ANTIBODY IL4 USED FOR TREATMENT OF DISORDERS ASSOCIATED WITH FUNCTION OF IL4 | 1994 |
|
RU2162711C2 |
| METHOD OF PRODUCING DIMERIC FORM OF MUTANT IGA2M1-ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2023 |
|
RU2822889C1 |
